5ND-30326-33923 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-02
Registered in v-safe
2021-09-02
Dose 1 — Pfizer-BioNTech
2021-09-03
Survey response — days 1–6 daily, dose 1
MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Had symptoms after 2 hours of injection, lasted 2-4 hours

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-05
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Good

Free text: Minor sore throat / running nose

MedDRA releases: 2021-09,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-02	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-03

Systemic reaction (other): Had symptoms after 2 hours of injection, lasted 2-4 hours

2021-09-05

Systemic reaction (other): Minor sore throat / running nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Adverse reaction	✓	·	✓
SRO	Oropharyngeal pain	✓	·	✓
SRO	Rhinorrhoea	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release